TCR2 Therapeutics Competitors and Similar CompaniesClear all
TCR2 Therapeutics's competitors and similar companies include PolyPid, VBI Vaccines, MetaboGen AB and Metabolon.
 TCR2 Therapeutics TCR2 Therapeutics is a discovery-stage pharmaceutical company focused on engineering T cells for cancer therapy. |  PolyPid PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API). |  VBI Vaccines VBI Vaccines is a biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. |  MetaboGen AB As a pioneering company, MetaboGen is addressing the microbiome to understand health and disease. |  Metabolon Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research. | |
Founding Date | Founding Date 2015 | Founding Date 2008 | Founding Date 2001 | Founding Date 2011 | Founding Date 2000 |
Type | Type Subsidiary | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Petah Tikva, IL HQ Summit, US | Locations Cambridge, US HQ Ottawa, CA Rehovot, IL | Locations Mölndal, SE HQ Stockholm, SE | Locations Morrisville, US HQ Hallbergmoos, DE München, DE |
Employees | Employees 445% increase | Employees 57 | Employees 12314% increase | Employees 1 | Employees 1911% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 23.7 m | Valuation ($) 1.9 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $8.7m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($151.8m) (FY, 2022) | Net income ($34.2m) (FY, 2025) | Net income ($92.8m) (FY, 2023) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 173.3m | Total funding raised $ 103.8m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 95.4m |
For sources of this data, please see the company profile
View Company Profiles
PolyPid
HQ
Petah Tikva, IL
Employees
57
PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API).
View companyVBI Vaccines
HQ
Cambridge, US
Employees
123↑ 14% increase
VBI Vaccines is a biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.
View companyMetaboGen AB
HQ
Mölndal, SE
Employees
1
As a pioneering company, MetaboGen is addressing the microbiome to understand health and disease.
View companyMetabolon
HQ
Morrisville, US
Employees
191↑ 1% increase
Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research.
View company